FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileVitrafy Life Sciences Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
VFY.AX
Vitrafy Life Sciences Ltd. Stock AnalysisComprehensive stock analysis for Vitrafy Life Sciences Ltd. (VFY.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisVFY.AX
VFY.AX
Vitrafy Life Sciences Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
VFY.AX
  1. Home
  2. Stocks
  3. Vitrafy Life Sciences Ltd.

Vitrafy Life Sciences Ltd.

🇦🇺VFY.AX•ASX

Vitrafy Life Sciences Ltd.

🇦🇺VFY.AX•ASX

Your view on VFY.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Vitrafy Life Sciences Ltd.

Industry
Medical - Specialties
Sector
Healthcare
CEO
Brenton Michael Leslie Owens
Headquarters
Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
Industry
Medical - Specialties
Sector
Healthcare
CEO
Brenton Michael Leslie Owens
Headquarters
Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
Description

Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction.

The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems.

Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Vitrafy Life Sciences Ltd.. Starting points for Vitrafy Life Sciences Ltd.: EPS -AUD 0.22, beta 1.93 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Vitrafy Life Sciences Ltd.. Vitrafy Life Sciences Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Vitrafy Life Sciences Ltd.. Trailing twelve-month EPS for Vitrafy Life Sciences Ltd. stands at -AUD 0.22. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Vitrafy Life Sciences Ltd.. Vitrafy Life Sciences Ltd. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold VFY.AX12 companies
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
PMSNFProteome Sciences plcHealthcareOTC$11.8M
QDELQuidelOrtho CorporationHealthcareNASDAQ$570.9M
SDCCQSmileDirectClub, Inc.HealthcareOTC$13,395
SIShoulder Innovations, Inc.HealthcareNYSE$421.6M
SSMXFSysmex CorporationHealthcareOTC$5.4B
SSMXYSysmex CorporationHealthcareOTC$5.5B
STESTERIS plcHealthcareNYSE$24.8B
TRIBTrinity Biotech plcHealthcareNASDAQ$126.4M
UAHCUnited American Healthcare CorporationHealthcareOTC$1.1M
UEECUnited Health Products, Inc.HealthcareOTC$14.9M
VMTHFVenus Medtech (Hangzhou) Inc.HealthcareOTC$184.7M
VVVVvVARDIS HOLDING AG Class AHealthcareNYSE$558.7M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Vitrafy Life Sciences Ltd.. Coverage tracks Vitrafy Life Sciences Ltd. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Vitrafy Life Sciences Ltd.

VFY.AX AnalysisWeak
Past
5
Growth
0
Health
0
Profit
0
Value
0